Plasma hyaluronan levels predict major adverse cardiovascular events in urological sepsis

被引：0
|
作者：
Momota, M. [1 ]
Fujita, N. [1 ]
Tobisawa, Y. [2 ]
Yoneyama, T. [3 ]
Soma, O. [1 ]
Noro, D. [1 ]
Ito, H. [4 ]
Yoshikawa, H. [5 ]
Ohyama, C. [1 ]
Hatakeyama, S. [1 ]
机构：
[1] Hirosaki Univ Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan
[2] Gifu Univ Grad Sch Med, Dept Urol, Gifu, Japan
[3] Hirosaki Univ Grad Sch Med, Dept Glycotechnol, Ctr Adv Med Res, Hirosaki, Aomori, Japan
[4] Aomori Rosai Hosp Hachinohe Japan, Dept Urol, Hachinohe, Aomori, Japan
[5] Mutsu Gen Hosp, Dept Urol, Mutsu, Aomori, Japan
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P097
引用
收藏
页码：S130 / S131
页数：2
相关论文
共 50 条
  • [21] A paradigm shift for cardiovascular outcome evaluation in diabetes: Major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE)
    Rastogi, Ashu
    Sudhayakumar, Anand
    Schaper, Nicolaas C.
    Jude, Edward B.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2023, 17 (11)
  • [22] Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions
    Adusumalli, Srikanth
    McCarthy, Cian
    Magaret, Craig
    Rhyne, Rhonda
    Jaffer, Farouc
    Januzzi, James
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B51 - B51
  • [23] Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions
    Adusumalli, Srikanth
    Mccarthy, Cian P.
    Magaret, Craig A.
    Rhyne, Rhonda F.
    Jaffer, Farouc A.
    Januzzi, James L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 242 : 25 - 31
  • [24] Liver Steatosis and Liver Fibrosis Predict Major Adverse Cardiovascular Events in the CLEAR Outcomes Trial
    de Jong, Vivian
    Saidi, Alina
    Cabezas, Manuel Castro
    Nissen, Steven
    Sasiela, William
    Li, Na
    Bloedon, Leanne
    Lincoff, Abraham
    Nicholls, Stephen
    Grobbee, Diederick
    CIRCULATION, 2024, 150
  • [25] Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study
    Ma, Zheng
    Zhao, Lei
    Martin, Sara
    Zhang, Yeping
    Dong, Ying
    Zhong, Jiu-Chang
    Yang, Xin-Chun
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [26] Elevated plasma BNP levels predict cardiovascular events in patients with CHF and diabetes
    不详
    Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (5): : 383 - 384
  • [27] Association Between Atherogenic Index of Plasma and Risk of Incident Major Adverse Cardiovascular Events
    Zhi, Yao-Wei
    Chen, Run-Gui
    Zhao, Ji-Wei
    Zhou, Shu-Xuan
    He, Zhi-Jie
    INTERNATIONAL HEART JOURNAL, 2024, 65 (01) : 39 - 46
  • [28] Plasma Ceramides: A Novel Predictor of Major Adverse Cardiovascular Events After Coronary Angiography
    Meeusen, Jeffrey W.
    Donato, Leslie J.
    Bryant, Sandra C.
    Baudhuin, Linnea M.
    Berger, Peter B.
    Jaffe, Allan S.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (08) : 1933 - 1939
  • [29] Association Between Plasma Total Testosterone and Major Adverse Cardiovascular Events in Hypertensive Patients
    Ioakeimidis, Nikolaos
    Vlachopoulos, Charalambos
    Aznaouridis, Konstantinos
    Terentes-Printzios, Dimitrios
    Aggelis, Athanasios
    Abdelrasoul, Mahmoud
    Aggelakas, Aggelos
    Synodinos, Alexandros
    Lazaros, George
    Stefanadis, Christodoulos
    CIRCULATION, 2012, 126 (21)
  • [30] Thrombospondin-1 plasma levels associated with in-hospital major adverse cardiovascular events in patients with acute coronary syndrome
    Ma, Zheng
    Wang, Meiping
    Xu, Xiaorong
    Zhang, Yeping
    Zhong, Jiuchang
    Chen, Mulei
    Su, Pixiong
    Zhao, Lei
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 375 : 98 - 103
12345